US responds to drugmakers’ IRA counteroffers as Medicare price negotiations continue

CMS wants further discussions with pharma companies that are participating in IRA price negotiations, HHS announced on Tuesday.

The agency said it has responded to counteroffers proposed by all of the participating manufacturers, but declined to comment further. According to CMS’ guidelines, the agency will now…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks